Relapsed Acute Lymphoblastic Leukemia (ALL) Recruiting Phase 1 Trials for Palbociclib (DB09073)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04996160	Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)	Treatment	Bortezomib (DB00188) Dexamethasone (DB01234) Doxorubicin (DB00997) Palbociclib (DB09073)